Trial Condition(s):

Sunscreening Agents

Sun Protection Factor Assay (SPF Assay 202/2016)

Bayer Identifier:

19202

ClinicalTrials.gov Identifier:

NCT02930785

EudraCT Number:

Not Available

Study Completed

Trial Purpose

To evaluate the Sun Protection Factor efficacy on human skin.

Inclusion Criteria
- Fitzpatrick Skin Type l, ll and/or lll for UVB testing. Fitzpatrick Skin Type ll, lll and/or lV for UVA testing.
- Male and female.
- Aged between 18-70 years old.
- Good health as determined from the HRL SHF (Subject History Form).
- Signed and dated Informed Consent Form.
- Signed and dated HIPAA (Health Insurance Portability and Accountability Act) form.
- An unambiguous MED (Minimal Erythema Dose) or MPPD (Minimal Persistent Pigment Darkening Dose).
Exclusion Criteria
- Subjects on test at any other research laboratory or clinic.
- Known allergy or sensitivity to sunscreens, cosmetics and toiletries, topical drugs and/or ultraviolet light.
- Pre-existing dermatologic conditions which have been diagnoses by a medical professional (e.g. psoriasis, eczema, etc.) which would interfere with this study.
- Pre-existing other medical conditions (e.g. adult asthma, diabetes).
- Treatment with antihistamines or corticosteroids within one week prior to initiation of the test.
- Treatment with antibiotics within two weeks prior to initiation of the test.
- Chronic medication which could affect the results of the study.
- Known pregnant or nursing women.

Trial Summary

Enrollment Goal
5
Trial Dates
black-arrow
Phase
N/A
Could I receive a placebo?
No
Products
BAY987517
Accepts Healthy Volunteers
Yes

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Union, United States, 07083

Status
Completed
 

Trial Design